Co-Diagnostics Overview

  • Founded
  • 2012
  • Status
  • Public
  • Employees
  • 29
  • Stock Symbol
  • CODX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $18.11
  • (As of Tuesday Closing)

Co-Diagnostics General Information


Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Application Software
Other Industries
Social/Platform Software
Other Healthcare Technology Systems
Stock Exchange
Primary Office
  • 2401 South Foothill Drive
  • Suite D
  • Salt Lake City, UT 84109
  • United States
+1 (801) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Co-Diagnostics Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.11 $17.47 $0.85 - $29.72 $480M 27.5M 6.49M -$0.32

Co-Diagnostics Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 208,190 12,979 18,935 27,802
Revenue 1,760 215 40 8
EBITDA (5,863) (6,060) (6,106) (6,607)
Net Income (5,892) (6,196) (6,272) (6,959)
Total Assets 20,480 2,215 1,553 4,662
Total Debt 0 0 1,909 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Co-Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Co-Diagnostics‘s full profile, request access.

Request a free trial

Co-Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
Dwight Egan Chief Executive Officer & Chairman
Reed Benson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Brent Satterfield Ph.D Chief Scientific Officer

1 Former Executive

Co-Diagnostics Board Members (4)

To view Co-Diagnostics‘s full board member team, request access »
Name Representing Role Since
000000 0000 Co-Diagnostics Chief Executive Officer & Chairman 000 0000
00000 000000 Co-Diagnostics Board Member 000 0000
0000000 000000 00 Co-Diagnostics Board Member 000 0000

1 Former Board Member

Co-Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Co-Diagnostics‘s full profile, request access.

Request a free trial

Co-Diagnostics Investments (1)

To view Co-Diagnostics‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 25-Jul-2017 00000 0000000 Other Healthcare

Ready to get started?

Request a free trial